MAGE-TAB Version 1.1 Comment[MetaboBank accession] MTBKS276 Study Title Ecological and functional characteristics of gut phageome in patients with multiple sclerosis Study Description This study revealed dysbiosis of the human gut phageome in multiple sclerosis patients. This study also revealed the concentrations of human fecal metabolites in multiple sclerosis patients. Experimental Design case control design Experimental Factor Name disease Experimental Factor Type disease Person Last Name Suda Kiguchi Takewaki Shindo Person First Name Wataru Yuya Daiki Chie Person Mid Initials Person Affiliation Laboratory for Symbiotic Microbiome Sciences Center for Integrative Medical Sciences, RIKEN Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo Department of Immunology, National Center of Neurology and Psychiatry, National Institute of Neuroscience Laboratory for Symbiotic Microbiome Sciences Center for Integrative Medical Sciences, RIKEN Person Roles submitter submitter submitter submitter PubMed ID Publication DOI Protocol Name Sample collection Extraction 1 Extraction 2 Chromatography 1 Chromatography 2 Mass spectrometry 1 Mass spectrometry 2 Data processing 1 Data processing 2 Metabolite identification 1 Metabolite identification 2 Protocol Type Sample collection Extraction Extraction Chromatography Chromatography Mass spectrometry Mass spectrometry Data processing Data processing Metabolite identification Metabolite identification Protocol Description Fecal samples were collected from each individual. The collected fresh feces were stored under anaerobic con- ditions in an AneroPack (Mitsubishi Gas Chemical Co. Inc., Tokyo, Japan) at 4°C. Within 36 h after sampling, the feces were frozen in 20% glycerol (Wako Pure Chemical Industries, Osaka, Japan)/phos- phate buffer saline (PBS) solution (Life Technologies, Tokyo, Japan) by liquid nitrogen and stored at -80°C until ready for use. "Approximately 50 mg of fresh feces was suspended in 1 mL of PBS (FUJIFILM Wako) at 4°C, and then filtered using Steriflip filters (Merck) with a pore size of 100 μm. The filtered suspension was used for the analysis of water-soluble metabolites. 100 μL aliquot of the fecal suspension were added to 150 μL methanol (Honeywell-Riedel-de Ha), 35 μL Milli-Q water, 15 μL Milli-Q water containing an internal standard (1 mM/L 2-isopropylmalic acid) and 60 μL chloroform (FUJIFILM Wako). The solution was then shaken at 1,200 rpm for 30 minutes at 37°C. After centrifugation at 16,000 × g for five minutes at room temperature, 250 μL of the supernatant were transferred to a new tube and 200 μL of Milli-Q water was added. After mixing, the solution was centrifuged at 16,000 × g for five minutes at room temperature, and 250 μL of the supernatant was transferred to a new tube. Samples were evaporated to dryness using a vacuum evaporator system (CentriVap Centrifugal Vacuum Concentrator, LABCONCO) for 20 minutes at 40°C and lyophilized using a freeze dryer. Dried extracts were derivatized with 40 μl of 20 mg/ml methoxyamine hydrochloride (Sigma-Aldrich) dissolved in pyridine and shaken at 1,200 rpm for 90 min at 30 °C. The solution was then mixed with 20 μl of N-methyl-N-trimethylsilyl-trifluoroacetamide (MSTFA, GL Science) and incubated for 30 min at 37 °C with shaking at 1,200 rpm. After derivatization, the samples were centrifuged at 16,000g for 5 min at room temperature, and the supernatant was transferred to a glass vial." "Approximately 50 mg of fresh feces was suspended in 1 mL of PBS (FUJIFILM Wako) at 4°C, and then filtered using Steriflip filters (Merck) with a pore size of 100 μm. The filtered suspension was used for the analysis of short-chain fatty acids. 90 μL aliquot of fecal suspension was added to 10 μL Milli-Q water containing internal standards (2 mM [1,2-13C2]acetate, 2 mM [2H7]butyrate and 2 mM Crotonic acid). Then, 50 μl of hydrochloric acid (HCl) and 200 μl of diethyl ether were added to the solution and mixed well. After centrifugation at 3,000g for 10 min, 80 μl of the organic layer was transferred to a glass vial and 16 μl N-tert-butyldimethylsilyl-N-trifluoroacetamide (MTBSTFA, Sigma-Aldrich) was added to derivatize the samples. The vials were incubated at 80 °C for 20 min and allowed to stand for 48 h before injection." The analysis was performed using a GC-MS/MS platform on the Shimadzu GCMS-TQ8040 triple quadrupole mass spectrometer (Shimadzu) with a capillary column (BPX5, SGE Analytical Science). The GC oven was programmed as follows: 60 °C held for 2 min, increased to 330 °C (15 °C /min), and finally 330 °C held for 3.45 min. GC was operated in constant linear velocity mode set to 39 cm/s. The detector and injector temperatures were 200 °C and 250 °C, respectively. Injection volume was set at 1 μl with a split ratio of 1:30. The analysis was performed using a Shimadzu GCMS-TQ8040 triple quadrupole mass spectrometer with a capillary column (BPX5). The GC oven was programmed as follows: 60 °C held for 3 min, increased to 130 °C (8 °C/min), increased to 330 °C (30 °C/min) and finally 330 °C held for 3 min. The detector and injector temperatures were 230 °C and 250 °C, respectively. GC was operated in constant linear velocity mode set to 40 cm/s. Injection volume was set at 1 μl with a split ratio of 1:30. The analysis of hydrophilic metabolomics was conducted using a gas chromatography-tandem mass spectrometry platform on a Shimadzu GCMS-TQ8040 triple quadrupole mass spectrometer (Shimadzu) in electron impact (EI) mode. The ion source and transfer line temperatures were maintained at 200 °C and 280 °C, respectively. The electron energy was maintained at a value 0.1 kV above the optimized autotune setting. Quantitative analysis was performed in multiple reaction monitoring (MRM) mode using argon as the collision gas. SCFA analysis was conducted using a gas chromatography-tandem mass spectrometry platform on a Shimadzu GCMS-TQ8040 triple quadrupole mass spectrometer (Shimadzu) in electron impact (EI) mode. The ion source and transfer line temperatures were maintained at 230 °C and 260 °C, respectively. The electron energy was set relative to the autotune result. Quantitative analysis was performed in multiple reaction monitoring (MRM) mode using argon as the collision gas. The GC/MS/MS data were processed by LabSolutions Insight ver. 4.0 SP2 (Shimadzu). Peak integration was performed automatically with manual verification. The GC/MS/MS data were processed by LabSolutions Insight ver. 4.0 SP2 (Shimadzu). Peak integration was performed automatically with manual verification. The GC/MS/MS data were calculated the concentration by LabSolutions Insight ver. 4.0 SP2 (Shimadzu). Quantification was conducted using MRM transitions with peak area ratios relative to internal standards (2-isopropylmalic acid) added prior to sample preparation. Quantification was performed using a single-point calibration with a solvent-based standard (processed/MTBKS276_hydrophilic-STD.txt) at 100 μM. The GC/MS/MS data were calculated the concentration by LabSolutions Insight ver. 4.0 SP2 (Shimadzu). Quantification was conducted using MRM transitions with peak area ratios relative to internal standards ([1,2-13C2]acetate, [2H7]butyrate, and Crotonic acid) added prior to sample preparation. Quantification was performed using at three concentration levels (10, 100, and 1000 μM; processed/MTBKS276_SCFA-STD.txt) with linear regression. Protocol Parameters Post extraction;Derivatization Post extraction;Derivatization Chromatography instrument;Autosampler model;Column model;Column type;Temperature;Guard column Chromatography instrument;Autosampler model;Column model;Column type;Temperature;Guard column Scan polarity;Scan m/z range;Instrument;Ion source;Mass analyzer Scan polarity;Scan m/z range;Instrument;Ion source;Mass analyzer Protocol Hardware Protocol Software Public Release Date 2026-04-17 Term Source Name Term Source File Term Source Version SDRF File MTBKS276.sdrf.txt Comment[Study type] metabolomics Comment[Experiment type] gas chromatography-mass spectrometry Comment[Submission type] GC-MS Comment[BioProject] PRJDB39729 Comment[Related study] Comment[Contributor] Comment[Submission Date] 2026-02-17 Comment[Last Update Date] 2026-04-17